United States Biotechnology & Medical Research

Tarsus Pharmaceuticals, Inc. (TARS)

Track

Over the past 90 days, Tarsus Pharmaceuticals, Inc. insiders have engaged in 12 transactions, resulting in a net negative value of approximately $877,436. All activity consisted of sales, primarily planned or proposed, involving key executives and directors. These transactions follow the company's recent earnings report, during which the stock price has declined by 8.0%.
Ticker: TARS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tarsus Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 17 Jun 2026
Value US$4,035,330.33 | Price 322.56 | Shares 67,928 (-8.3%)
Planned sale 17 Jun 2026
Value US$816,599.17 | Price 126.37 | Shares 79,270 (+38.3%)
Planned sale 17 Jun 2026
Value US$280,601.68 | Price 61.24 | Shares 4,582 (-0.5%)
Planned sale 17 Jun 2026
Value US$280,601.68 | Price 61.24 | Shares 4,582 (-0.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
67,928 -8.3%
322.56
US$4,035,330 		67,928 -8.3% 322.56 US$4,035,330
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
79,270 +38.3%
126.37
US$816,599 		79,270 +38.3% 126.37 US$816,599
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
6,660 -2.4%
439.64
US$1,916,123 		6,660 -2.4% 439.64 US$1,916,123
2026-06-22 2026-06-17 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
4,582 -0.5%
61.24
US$280,602 		4,582 -0.5% 61.24 US$280,602
2026-06-17 2026-06-17 PrS Proposed sale
3.5
BOBAK AZAMIAN

OFFICER

Officer
10,000
61.55
US$615,473 		10,000 61.55 US$615,473
2026-06-17 2026-06-16 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
14,396 -20.2%
60.95
US$877,436 		14,396 -20.2% 60.95 US$877,436
2026-06-16 2026-06-16 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
14,396
60.95
US$877,459 		14,396 60.95 US$877,459
2026-06-17 2026-06-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
1,928 -1.8%
62.94
US$121,348 		1,928 -1.8% 62.94 US$121,348
2026-06-17 2026-06-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
10,572 -8.9%
61.97
US$655,147 		10,572 -8.9% 61.97 US$655,147
2026-06-17 2026-06-15 PlS Planned sale
Goodrich Katherine
Non-Executive Director
2,954 -57.0%
62.08
US$183,384 		2,954 -57.0% 62.08 US$183,384
2026-06-15 2026-06-15 PrS Proposed sale
1.5
William J Link

Director

Non-Executive Director
12,500
62.12
US$776,498 		12,500 62.12 US$776,498
2026-06-15 2026-06-15 PrS Proposed sale
Goodrich Katherine

Director

Non-Executive Director
2,954
62.08
US$183,384 		2,954 62.08 US$183,384
2026-03-24 2026-03-20 PlS Planned sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
2,989 -3.5%
66.75
US$199,516 		2,989 -3.5% 66.75 US$199,516
2026-03-20 2026-03-20 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
2,989
66.75
US$199,516 		2,989 66.75 US$199,516
2026-03-19 2026-03-19 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,231 -6.2%
67.00
US$283,477 		4,231 -6.2% 67.00 US$283,477
2026-03-19 2026-03-19 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,174 -10.6%
67.00
US$279,658 		4,174 -10.6% 67.00 US$279,658
2026-03-19 2026-03-19 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,440 -6.7%
67.00
US$297,480 		4,440 -6.7% 67.00 US$297,480
2026-03-19 2026-03-19 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
390 -1.6%
67.00
US$26,130 		390 -1.6% 67.00 US$26,130
2026-03-19 2026-03-19 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,186 -4.8%
67.00
US$146,462 		2,186 -4.8% 67.00 US$146,462
2026-03-19 2026-03-19 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
4,589 -5.1%
67.00
US$307,463 		4,589 -5.1% 67.00 US$307,463
2026-03-19 2026-03-19 S Sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
11,964 -26.4%
67.00
US$801,588 		11,964 -26.4% 67.00 US$801,588
2026-03-19 2026-03-19 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
2,186
67.00
US$146,459 		2,186 67.00 US$146,459
2026-03-19 2026-03-19 PrS Proposed sale
3.5
Mottiwala Aziz

Officer

Officer
4,440
67.00
US$297,475 		4,440 67.00 US$297,475
2026-03-19 2026-03-19 PrS Proposed sale
3.5
Azamian Bobak R.

Officer; Director

Executive Director
11,964
67.00
US$801,574 		11,964 67.00 US$801,574
2026-03-19 2026-03-19 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
4,174
67.00
US$279,653 		4,174 67.00 US$279,653
2026-03-19 2026-03-19 PrS Proposed sale
3.2
Wahl Bryan

Officer

Officer
4,231
67.00
US$283,472 		4,231 67.00 US$283,472
2026-03-19 2026-03-19 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
4,589
67.00
US$307,457 		4,589 67.00 US$307,457
2026-03-19 2026-03-19 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
390
67.00
US$26,130 		390 67.00 US$26,130
2026-03-19 2026-03-18 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,125 -5.7%
68.71
US$283,429 		4,125 -5.7% 68.71 US$283,429
2026-03-19 2026-03-18 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,071 -9.4%
68.71
US$279,718 		4,071 -9.4% 68.71 US$279,718
2026-03-19 2026-03-18 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,330 -6.2%
68.71
US$297,514 		4,330 -6.2% 68.71 US$297,514
2026-03-19 2026-03-18 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
379 -1.6%
68.71
US$26,041 		379 -1.6% 68.71 US$26,041
2026-03-19 2026-03-18 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,133 -4.5%
68.71
US$146,558 		2,133 -4.5% 68.71 US$146,558
2026-03-19 2026-03-18 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
3,610 -3.8%
68.71
US$248,043 		3,610 -3.8% 68.71 US$248,043
2026-03-19 2026-03-18 S Sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
11,667 -20.4%
68.71
US$801,640 		11,667 -20.4% 68.71 US$801,640
2026-03-18 2026-03-18 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
4,071
68.71
US$279,718 		4,071 68.71 US$279,718
2026-03-18 2026-03-18 PrS Proposed sale
3.2
Wahl Bryan

Officer

Officer
4,125
68.71
US$283,428 		4,125 68.71 US$283,428
2026-03-18 2026-03-18 PrS Proposed sale
3.5
Azamian Bobak R.

Officer; Director

Executive Director
11,667
68.71
US$801,637 		11,667 68.71 US$801,637
2026-03-18 2026-03-18 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
3,610
68.71
US$248,042 		3,610 68.71 US$248,042
2026-03-18 2026-03-18 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
379
68.71
US$26,041 		379 68.71 US$26,041
2026-03-18 2026-03-18 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
2,133
68.71
US$146,558 		2,133 68.71 US$146,558
2026-03-18 2026-03-18 PrS Proposed sale
3.5
Mottiwala Aziz

Officer

Officer
4,330
68.71
US$297,513 		4,330 68.71 US$297,513
2026-03-19 2026-03-17 S Sale
3.2
Wahl Bryan

General Counsel

Officer
4,084 -5.3%
69.42
US$283,511 		4,084 -5.3% 69.42 US$283,511
2026-03-19 2026-03-17 S Sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
4,029 -8.5%
69.42
US$279,693 		4,029 -8.5% 69.42 US$279,693
2026-03-19 2026-03-17 S Sale
3.5
Mottiwala Aziz

Chief Commercial Officer

Officer
4,286 -5.8%
69.42
US$297,534 		4,286 -5.8% 69.42 US$297,534
2026-03-19 2026-03-17 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
375 -1.5%
69.42
US$26,032 		375 -1.5% 69.42 US$26,032
2026-03-19 2026-03-17 S Sale
2.5
Farrow Jeffrey S

See Remarks

Officer
2,111 -4.2%
69.42
US$146,546 		2,111 -4.2% 69.42 US$146,546
2026-03-19 2026-03-17 S Sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
3,125 -3.2%
69.42
US$216,938 		3,125 -3.2% 69.42 US$216,938
2026-03-19 2026-03-17 S Sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
10,972 -16.1%
69.42
US$761,676 		10,972 -16.1% 69.42 US$761,676
2026-03-17 2026-03-17 PrS Proposed sale
3.5
Azamian Bobak R.

Officer; Director

Executive Director
10,972
69.41
US$761,618 		10,972 69.41 US$761,618
2026-03-17 2026-03-17 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
3,125
69.41
US$216,921 		3,125 69.41 US$216,921
2026-03-17 2026-03-17 PrS Proposed sale
2.5
Farrow Jeffrey S

Officer

Officer
2,111
69.41
US$146,534 		2,111 69.41 US$146,534
2026-03-17 2026-03-17 PrS Proposed sale
3.2
Wahl Bryan

Officer

Officer
4,084
69.41
US$283,490 		4,084 69.41 US$283,490
2026-03-17 2026-03-17 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
4,029
69.41
US$279,672 		4,029 69.41 US$279,672
2026-03-17 2026-03-17 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
375
69.41
US$26,031 		375 69.41 US$26,031
2026-03-17 2026-03-17 PrS Proposed sale
3.5
Mottiwala Aziz

Officer

Officer
4,286
69.41
US$297,511 		4,286 69.41 US$297,511
2026-03-18 2026-03-16 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
493 -0.4%
69.75
US$34,387 		493 -0.4% 69.75 US$34,387
2026-03-18 2026-03-16 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
8,378 -6.7%
69.03
US$578,333 		8,378 -6.7% 69.03 US$578,333
2026-03-18 2026-03-16 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
3,629 -2.8%
68.09
US$247,099 		3,629 -2.8% 68.09 US$247,099
2026-03-16 2026-03-16 PrS Proposed sale
3.5
WILLIAM J LINK

DIRECTOR

Non-Executive Director
12,500
68.78
US$859,787 		12,500 68.78 US$859,787
2026-03-05 2026-03-04 PlS Planned sale
3.4
Neervannan Seshadri

Chief Operating Officer

Officer
8,366 -10.6%
76.67
US$641,421 		8,366 -10.6% 76.67 US$641,421
2026-03-04 2026-03-04 PrS Proposed sale
3.4
Neervannan Seshadri

Officer

Officer
8,366
76.67
US$641,421 		8,366 76.67 US$641,421
2026-01-06 2026-01-02 PlS Planned sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
893 -3.7%
82.93
US$74,056 		893 -3.7% 82.93 US$74,056
2026-01-06 2026-01-02 PlS Planned sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
835 -3.3%
81.90
US$68,386 		835 -3.3% 81.90 US$68,386
2026-01-06 2026-01-02 PlS Planned sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
8,122 -24.4%
80.71
US$655,527 		8,122 -24.4% 80.71 US$655,527
2026-01-06 2026-01-02 PlS Planned sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
5,715 -14.7%
80.09
US$457,714 		5,715 -14.7% 80.09 US$457,714
2026-01-02 2026-01-02 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
15,565
81.38
US$1,266,680 		15,565 81.38 US$1,266,680
2025-12-30 2025-12-24 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
557 -0.1%
83.54
US$46,532 		557 -0.1% 83.54 US$46,532
2025-12-30 2025-12-24 PlS Planned sale
3.5
Azamian Bobak R.

President/CEO and Board Chair

Executive Director
5,443 -0.6%
82.41
US$448,558 		5,443 -0.6% 82.41 US$448,558
2025-12-29 2025-12-24 PrS Proposed sale
3.5
BOBAK AZAMIAN

OFFICER

Officer
6,000
82.51
US$495,089 		6,000 82.51 US$495,089
2025-12-18 2025-12-16 PlS Planned sale
3.2
Whitfield Dianne C.

Chief Human Resources Officer

Officer
7,397 -16.0%
80.10
US$592,500 		7,397 -16.0% 80.10 US$592,500
2025-12-17 2025-12-16 S Sale
3.6
Lin Elizabeth Yeu

Chief Medical Officer

Officer
2,078 -8.7%
79.50
US$165,201 		2,078 -8.7% 79.50 US$165,201
2025-12-16 2025-12-16 PrS Proposed sale
3.6
Lin Elizabeth Yeu

Officer

Officer
2,078
79.50
US$165,202 		2,078 79.50 US$165,202
2025-12-16 2025-12-16 PrS Proposed sale
3.2
Whitfield Dianne C.

Officer

Officer
7,397
80.10
US$592,500 		7,397 80.10 US$592,500
2025-12-17 2025-12-15 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
4,766 -100.0%
81.50
US$388,429 		4,766 -100.0% 81.50 US$388,429
Explore more

More insider trading research around Tarsus Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America